Microbiome & Chronic Diseases

Evidence Based Medicine
Sign in

Disease ⇒ Metabolic syndrome {40000421}

Record Keys

Metabolic syndrome
Parent:[  ]


Initialisation date:[  ]
Other Terms:[  ]

Meta Information

MedDra ID:
MedDra Level:
ICD:[  ]
Category:[  ]
Zone:[  ]
Mechanism:[  ]


[  ]

References Notes

[  ]

Shared Reference Notes

  • [1.1
    - Oral supplementation with the alive A. Mucinophila prevente the reduction of 2-PG and 1-PG levels observed upon the progression of the metabolic syndrome.
  • [1.5
    - The protective association between adherence to the Mediterranean diet and cardiometabolic disease risk is significantly stronger among participants with decreased abundance of Prevotella copri.
  • [1.6
    - D. welbionis abundance was present in up to 70% of the general population. Furthermore, its absolute abundance in the fecal microbiota of people with obesity suffering from metabolic syndrome was inversely correlated with body mass index, fasting glucose and glycated hemoglobin. which is used to determine how well a person with diabetes has been managing their blood sugar over the previous months.
  • [1.9
    - Higher long-term PDI (plant-based diet index) was associated with the lower relative abundance of Peptostreptococcus, while this microbe was positively correlated with the high-sensitivity C-reactive protein and inversely associated with high-density lipoprotein cholesterol.
  • - MetS gut viromes exhibit decreased richness and diversity. They are enriched in phages infecting Streptococcaceae and Bacteroidaceae and depleted in those infecting Bifidobacteriaceae.
    - MetS-associated Roseburia VC (viral cluster) that is related to healthy control-associated Faecalibacterium and Oscillibacter VCs.
  • - Candidatus Heliusviridae, a highly widespread gut phage lineage found in 90+% of Metabolic syndrome participants.

Common References